Huncharek M
Massachusetts General Hospital, Harvard Medical School, Boston.
Cancer. 1992 Jun 1;69(11):2704-11. doi: 10.1002/1097-0142(19920601)69:11<2704::aid-cncr2820691113>3.0.co;2-f.
Although malignant mesothelioma is a relatively rare tumor, its incidence is rising. Much of the increase is attributable to widespread exposure to asbestos in past decades in asbestos-related industries. In recent years, it has become increasingly clear that mesothelioma risk is no longer confined to workers in the asbestos industry. This article reports a variety of recently identified "risk groups" and highlights the need for increased surveillance of these groups to document the occurrence of asbestos-related malignancy and the institution of measures for disease prevention.
